Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04912960
Other study ID # 170090
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 10, 2021
Est. completion date June 30, 2024

Study information

Verified date February 2024
Source Dr. Negrin University Hospital
Contact Jesús Villar, MD
Phone +34606860027
Email jesus.villar54@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Positive end-expiratory pressure (PEEP) has become an essential component of the care of critically ill patients who require ventilatory support. In 1975, several investigators published the effects of PEEP in 15 mechanically ventilated patients with acute respiratory failure (ARF) supported by mechanical ventilation. FiO2 ranged between 21% to 75% and the tidal volume between 13 to 15 mL/kg. PEEP was increased in 3 cmH2O steps until cardiac output fell. The aim was to identify the "optimum" PEEP level. "Best" PEEP was associated simultaneously with the best static compliance of the respiratory system, the greatest oxygen transport, and the lowest dead space fraction. That study established the basis for the use of PEEP in patients with ARF worldwide. Although currently patients with ARF are ventilated with much lower tidal volumes, that study has never been validated. It is unknow whether their findings are currently valid, generalizable, and reproducible.


Description:

With the application of PEEP, the baseline end-expiratory pressure in mechanically ventilated patients is elevated above atmospheric pressure. PEEP is applied generally to improve oxygenation, which is usually not observed unless there is a concomitant increase in the functional residual capacity, probably by preventing airway closure and recruiting previously unventilated alveoli. Almost 50 years after the publication of a pivotal work on how to choose the optimum level of PEEP in patients with ARF, our knowledge on lung physiology and pulmonary mechanics in patients requiring mechanical ventilation (MV) has improved. To date, most ARF patients on MV are managed with incremental PEEP levels. The team of investigators in this study has postulated that it is appropriate to assess whether the routine clinical practice of applying increasing levels of PEEP pursues the best oxygenation and the best compliance, or by contrary, it was a random finding by investigators back in 1975. For the current assessment of this approach at the bedside (gradual increase of PEEP to identify the optimum level of PEEP), the investigators cannot reproduce exactly that approach since current recommendations for ventilating patients with severe ARF include: (i) the use of tidal volumes between 4-8 ml/kg predicted body weight, (ii) monitoring cardiac output using a pulmonary artery catheter is not a routine clinical practice in critically ill patients, and (iii) measuring dead space fraction is not part of the routine management of patients with acute respiratory failure. The investigators in this study will assess in 15 mechanically ventilated patients with ARF whether the highest lung compliance during the identification of optimal PEEP in each patient coincides with the level of best oxygenation and ventilation. PEEP levels will be individualized in each patient, as part of common practice in the Post-Surgical Critical Care Unit of the hospital. Data from 15 patients requiring MV for >24 h due to ARF will be analyzed to identify the optimum PEEP level. Only data from patients in which the cause of ARF is of pulmonary origin (atelectasis, lung contusion, aspiration of gastric content, and lung infection) will be analyzed.


Recruitment information / eligibility

Status Recruiting
Enrollment 15
Est. completion date June 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Intubated patients requiring MV for >24 h - Age >18 years - Acute hypoxemic respiratory failure, defined as a PaO2/FiO2 <300 with an FiO2 =0.3 and PEEP=5 cmH2O. - ARF caused by pulmonary insults. Exclusion Criteria: - ARF from non-pulmonary origin. - Contraindications from high PEEP (severe head trauma or severe chest trauma). - Patients that cannot maintained supine position. - Uncorrected hypovolemia - Hemodynamic instability

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Mechanical ventilation
Optimum PEEP

Locations

Country Name City State
Spain Hospital Clinic Barcelona
Spain Hospital Universitario Dr. Negrin Las Palmas De Gran Canaria Las Palmas
Spain Hospital Universitario La Princesa Madrid

Sponsors (1)

Lead Sponsor Collaborator
Jesus Villar

Country where clinical trial is conducted

Spain, 

References & Publications (2)

Acute Respiratory Distress Syndrome Network; Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1301-8. doi: 10.1056/NEJM200005043421801. — View Citation

Suter PM, Fairley B, Isenberg MD. Optimum end-expiratory airway pressure in patients with acute pulmonary failure. N Engl J Med. 1975 Feb 6;292(6):284-9. doi: 10.1056/NEJM197502062920604. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary static compliance of the respiratory system ratio of tidal volume to pressure gradiente of the respiratory system at study enrollment
Primary oxygen transport Cardiac output multiply by oxygen content in arterial blood at study enrollment
Primary dead space fraction ratio of dead space to tidal volume at study enrollment
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04681040 - Risk Stratification of COVID-19 Using Urine Biomarkers
Active, not recruiting NCT04079829 - Postoperative Respiratory Abnormalities
Completed NCT03021824 - Severe ARDS: Generating Evidence
Active, not recruiting NCT02654327 - pRotective vEntilation With Veno-venouS Lung assisT in Respiratory Failure Phase 3
Completed NCT04693403 - Adult Respiratory Failure Intervention Study Africa N/A
Recruiting NCT04368975 - ARDS Caused by COVID-19
Recruiting NCT02050217 - NAVA Helmet in Pediatric Respiratory Failure Phase 3
Recruiting NCT03311087 - Conduct of Nasal High Flow Oxygen in Acute Respiratory Failure
Recruiting NCT03467854 - PK of Piperacillin/Tazobactam in Adults Undergoing ECMO
Completed NCT04664322 - High-flow Oxygen Therapy vs Non-invasive Ventilation: Comparison of Alveolar Recruitment in Acute Respiratory Failure
Completed NCT02167542 - Positive Pressure During Bronchoscopy N/A
Completed NCT03326830 - Prehospital High-Flow Nasal Oxygen Therapy N/A
Terminated NCT01937884 - Supplemental Parenteral Nutrition in Pediatric Respiratory Failure Phase 2